Literature DB >> 8800465

Antigen-mediated IGE receptor aggregation and signaling: a window on cell surface structure and dynamics.

D Holowka1, B Baird.   

Abstract

The high-affinity receptor for immunoglobulin E, Fc epsilon RI, serves as an archtype for multisubunit immunoreceptors that mediate cell activation in response to foreign antigens. Antigen-mediated aggregation of this receptor at the surface of mast cells and basophils initiates a biochemical cascade that uses nonreceptor tyrosine kinases as key participants in the earliest steps of this signal transduction process. Cross-linking of Fc epsilon RI with ligands of well-defined structure and valency has revealed detailed information about the fundamental requirements for functionally active receptor aggregates. Cross-linking-dependent changes in the interaction of these receptors with other cellular components have been characterized with biochemical and biophysical methods to develop a more complete view of signal initiation. Recent evidence suggests that this process involves the interaction of aggregated Fc epsilon RI with specialized plasma membrane domains that may localize important signaling molecules in the vicinity of aggregated receptors. Although these various studies were aimed toward understanding the operation of one cell surface receptor, they provide new insights into plasma membrane structure and dynamics that are generally relevant to the function of most nucleated mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8800465     DOI: 10.1146/annurev.bb.25.060196.000455

Source DB:  PubMed          Journal:  Annu Rev Biophys Biomol Struct        ISSN: 1056-8700


  31 in total

1.  A model for membrane patchiness: lateral diffusion in the presence of barriers and vesicle traffic.

Authors:  L A Gheber; M Edidin
Journal:  Biophys J       Date:  1999-12       Impact factor: 4.033

Review 2.  Negative signaling in health and disease.

Authors:  K M Coggeshall
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 3.  Signaling through sphingolipid microdomains of the plasma membrane: the concept of signaling platform.

Authors:  D C Hoessli; S Ilangumaran; A Soltermann; P J Robinson; B Borisch
Journal:  Glycoconj J       Date:  2000 Mar-Apr       Impact factor: 2.916

4.  The EGF receptor transmembrane domain: peptide-peptide interactions in fluid bilayer membranes.

Authors:  M R Morrow; C W Grant
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

5.  Steric effects on multivalent ligand-receptor binding: exclusion of ligand sites by bound cell surface receptors.

Authors:  W S Hlavacek; R G Posner; A S Perelson
Journal:  Biophys J       Date:  1999-06       Impact factor: 4.033

6.  Ultrafine membrane compartments for molecular diffusion as revealed by single molecule techniques.

Authors:  Kotono Murase; Takahiro Fujiwara; Yasuhiro Umemura; Kenichi Suzuki; Ryota Iino; Hidetoshi Yamashita; Mihoko Saito; Hideji Murakoshi; Ken Ritchie; Akihiro Kusumi
Journal:  Biophys J       Date:  2004-06       Impact factor: 4.033

7.  Rapid hop diffusion of a G-protein-coupled receptor in the plasma membrane as revealed by single-molecule techniques.

Authors:  Kenichi Suzuki; Ken Ritchie; Eriko Kajikawa; Takahiro Fujiwara; Akihiro Kusumi
Journal:  Biophys J       Date:  2005-01-28       Impact factor: 4.033

Review 8.  Synthetic multivalent ligands as probes of signal transduction.

Authors:  Laura L Kiessling; Jason E Gestwicki; Laura E Strong
Journal:  Angew Chem Int Ed Engl       Date:  2006-04-03       Impact factor: 15.336

9.  Trivalent antigens for degranulation of mast cells.

Authors:  Richard G Posner; Dianliang Geng; Seth Haymore; James Bogert; Israel Pecht; Arieh Licht; Paul B Savage
Journal:  Org Lett       Date:  2007-08-11       Impact factor: 6.005

Review 10.  Modeling for (physical) biologists: an introduction to the rule-based approach.

Authors:  Lily A Chylek; Leonard A Harris; James R Faeder; William S Hlavacek
Journal:  Phys Biol       Date:  2015-07-16       Impact factor: 2.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.